Prostaglandin E2 Induction during Mouse Adenovirus Type 1 Respiratory Infection Regulates Inflammatory Mediator Generation but Does Not Affect Viral Pathogenesis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  McCarthy, Mary K ^b   Levine, Rachael E ^a   Procario, Megan C ^a   McDonnell, Peter J ^a   Zhu, Lingqiao ^b   Mancuso, Peter ^a   Crofford, Leslie J ^c   Aronoff, David M ^b   Weinberg, Jason B ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; RANTES;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE RESPONSE; INFLAMMATION; LEUKOCYTE; MALE; MICROSOME; MOUSE; MOUSE ADENOVIRUS TYPE 1; MOUSE ADENOVIRUS TYPE 1 RESPIRATORY INFECTION; NONHUMAN; PNEUMONIA; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; REINFECTION; RESPIRATORY TRACT INFLAMMATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; WILD TYPE; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; MUTANT MOUSE STRAIN; PATHOGENICITY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; VIROLOGY;

ADENOVIRIDAE; ANIMALS; CHEMOKINE CCL5; CHEMOKINE CXCL1; DINOPROSTONE; INTERFERON-GAMMA; MALE; MICE; MICE, MUTANT STRAINS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; VIRUS REPLICATION;

EID: 84885812407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077628     Document Type: Article

References (58)

1. Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, et al. (2002) Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 291: 884-889. doi:10.1006/bbrc.2002.6531. PubMed: 11866447.
2. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I, (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 275: 32775-32782. doi:10.1074/jbc.M003504200. PubMed: 10922363.
3. Jakobsson PJ, Thorén S, Morgenstern R, Samuelsson B, (1999) Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96: 7220-7225. doi:10.1073/pnas.96.13.7220. PubMed: 10377395.
4. Jania LA, Chandrasekharan S, Backlund MG, Foley NA, Snouwaert J, et al. (2009) Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin E2 biosynthesis. Prostaglandins Other Lipid Mediat 88: 73-81. doi:10.1016/j.prostaglandins.2008.10.003. PubMed: 19010439.
5. Lovgren AK, Kovarova M, Koller BH, (2007) cPGES/p23 is required for glucocorticoid receptor function and embryonic growth but not prostaglandin E2 synthesis. Mol Cell Biol 27: 4416-4430. doi:10.1128/MCB.02314-06. PubMed: 17438133.
6. Trebino CE, Stock JL, Gibbons CP, Naiman BM, Wachtmann TS, et al. (2003) Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci USA 100: 9044-9049. doi:10.1073/pnas.1332766100. PubMed: 12835414.
7. Boulet L, Ouellet M, Bateman KP, Ethier D, Percival MD, et al. (2004) Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J Biol Chem 279: 23229-23237. doi:10.1074/jbc.M400443200. PubMed: 15016822.
8. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, et al. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275: 32783-32792. doi:10.1074/jbc.M003505200. PubMed: 10869354.
9. McCarthy MK, Weinberg JB, (2012) Eicosanoids and Respiratory Viral Infection: Coordinators of Inflammation and Potential Therapeutic Targets. Mediators Inflamm, 2012(2012): 1-13 PubMed: 22665949.
10. McCoy JM, Wicks JR, Audoly LP, (2002) The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 110: 651-658. doi:10.1172/JCI0215528. PubMed: 12208866.
11. Tavakoli S, Cowan MJ, Benfield T, Logun C, Shelhamer JH, (2001) Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. Am J Physiol Lung Cell Mol Physiol 280: L127-L133. PubMed: 11133502.
12. Betz M, Fox BS, (1991) Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 146: 108-113. PubMed: 1845802.
13. Snijdewint FG, Kaliński P, Wierenga EA, Bos JD, Kapsenberg ML, (1993) Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol 150: 5321-5329. PubMed: 8390534.
14. Bloom D, Jabrane-Ferrat N, Zeng L, Wu A, Li L, et al. (1999) Prostaglandin E2 enhancement of interferon-gamma production by antigen-stimulated type 1 helper T cells. Cell Immunol 194: 21-27. doi:10.1006/cimm.1999.1479. PubMed: 10357877.
15. Yao C, Sakata D, Esaki Y, Li Y, Matsuoka T, et al. (2009) Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat Med 15: 633-640. doi:10.1038/nm.1968. PubMed: 19465928.
16. Bancos S, Bernard MP, Topham DJ, Phipps RP, (2009) Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol 258: 18-28. doi:10.1016/j.cellimm.2009.03.007. PubMed: 19345936.
17. Ryan EP, Pollock SJ, Pollack SJ, Murant TI, Bernstein SH, et al. (2005) Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J Immunol 174: 2619-2626. PubMed: 15728468.
18. Roper RL, Brown DM, Phipps RP, (1995) Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE. J Immunol 154: 162-170. PubMed: 7995935.
19. Fedyk ER, Phipps RP, (1996) Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. Proc Natl Acad Sci U_S_A 93: 10978-10983. doi:10.1073/pnas.93.20.10978. PubMed: 8855294.
20. Roper RL, Graf B, Phipps RP, (2002) Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1. Immunol Lett 84: 191-198. doi:10.1016/S0165-2478(02)00185-2. PubMed: 12413736.
21. Liu T, Zaman W, Kaphalia BS, Ansari GAS, Garofalo RP, et al. (2005) RSV-induced prostaglandin E2 production occurs via cPLA2 activation: role in viral replication. Virology 343: 12-24. doi:10.1016/j.virol.2005.08.012. PubMed: 16153673.
22. Richardson JY, Ottolini MG, Pletneva L, Boukhvalova M, Zhang S, et al. (2005) Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy. J Immunol 174: 4356-4364. PubMed: 15778400.
23. Radi ZA, Meyerholz DK, Ackermann MR, (2010) Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection. Viral Immunol 23: 43-48. doi:10.1089/vim.2009.0042. PubMed: 20121401.
24. Sznajer Y, Westcott JY, Wenzel SE, Mazer B, Tucci M, et al. (2004) Airway eicosanoids in acute severe respiratory syncytial virus bronchiolitis. J Pediatr 145: 115-118. doi:10.1016/j.jpeds.2004.03.049. PubMed: 15238918.
25. Lee SM, Cheung CY, Nicholls JM, Hui KP, Leung CY, et al. (2008) Hyperinduction of Cyclooxygenase-2-Mediated Proinflammatory Cascade: A Mechanism for the Pathogenesis of Avian Influenza H5N1 Infection. J Infect Dis 198: 525-535. doi:10.1086/590499. PubMed: 18613795.
26. Woo PC, Tung ET, Chan K-H, Lau CC, Lau S, al et,. (2010) Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies. J Infect Dis 201: 346-353. doi:10.1086/649785. PubMed: 20030555.
27. Darwish I, Mubareka S, Liles WC, (2011) Immunomodulatory therapy for severe influenza. Expert Rev Anti Infect Ther 9: 807-822. doi:10.1586/eri.11.56. PubMed: 21810053.
28. Zhu H, Cong J-P, Yu D, Bresnahan WA, Shenk TE, (2002) Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci U_S_A 99: 3932-3937. doi:10.1073/pnas.052713799. PubMed: 11867761.
29. Seymour ML, Gilby N, Bardin PG, Fraenkel DJ, Sanderson G, et al. (2002) Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. J Infect Dis 185: 540-544. doi:10.1086/338570. PubMed: 11865407.
30. Carey MA, Bradbury JA, Seubert JM, Langenbach R, Zeldin DC, et al. (2005) Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J Immunol 175: 6878-6884. PubMed: 16272346.
31. Knipe D, Howley P, Griffin D, Lamb R, Martin M, et al. (2007) Adenoviridae: The Viruses and Their Replication. Fields Virology: pp. 2355-2436.
32. Culver CA, Laster SM, (2007) Adenovirus type 5 exerts multiple effects on the expression and activity of cytosolic phospholipase A2, cyclooxygenase-2, and prostaglandin synthesis. J Immunol 179: 4170-4179. PubMed: 17785856.
33. Crofford LJ, McDonagh KT, Guo S, Mehta H, Bian H, et al. (2005) Adenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2. J Gene Med 7: 288-296. doi:10.1002/jgm.661. PubMed: 15515144.
34. Weinberg JB, Stempfle GS, Wilkinson JE, Younger JG, Spindler KR, (2005) Acute respiratory infection with mouse adenovirus type 1. Virology 340: 245-254. doi:10.1016/j.virol.2005.06.021. PubMed: 16054189.
35. Procario MC, Levine RE, McCarthy MK, Kim E, Zhu L, et al. (2012) Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice. J Virol 86: 4194-4203. doi:10.1128/JVI.06967-11. PubMed: 22345470.
36. Weinberg JB, Lutzke ML, Efstathiou S, Kunkel SL, Rochford R, (2002) Elevated chemokine responses are maintained in lungs after clearance of viral infection. J Virol 76: 10518-10523. doi:10.1128/JVI.76.20.10518-10523.2002. PubMed: 12239330.
37. Anderson VE, Nguyen Y, Weinberg JB, (2009) Effects of allergic airway disease on mouse adenovirus type 1 respiratory infection. Virology 391: 25-32. doi:10.1016/j.virol.2009.06.009. PubMed: 19564030.
38. Nguyen Y, McGuffie BA, Anderson VE, Weinberg JB, (2008) Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis. Virology 380: 182-190. doi:10.1016/j.virol.2008.07.031. PubMed: 18768196.
39. Weinberg JB, Jensen DR, Gralinski LE, Lake AR, Stempfle GS, et al. (2007) Contributions of E1A to mouse adenovirus type 1 pathogenesis following intranasal inoculation. Virology 357: 54-67. doi:10.1016/j.virol.2006.08.013. PubMed: 16962154.
40. Nguyen Y, Procario MC, Ashley SL, O'Neal WK, Pickles RJ, et al. (2011) Limited effects of Muc1 deficiency on mouse adenovirus type 1 respiratory infection. Virus Res 160: 351-359. doi:10.1016/j.virusres.2011.07.012. PubMed: 21816184.
41. Moore ML, McKissic EL, Brown CC, Wilkinson JE, Spindler KR, (2004) Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase. J Virol 78: 5584-5590. doi:10.1128/JVI.78.11.5584-5590.2004. PubMed: 15140955.
42. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH, (1991) Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 253: 1417-1420. doi:10.1126/science.1910207. PubMed: 1910207.
43. Cauthen AN, Welton AR, Spindler KR, (2007) Construction of mouse adenovirus type 1 mutants. Methods Mol Med 130: 41-59. PubMed: 17401163.
44. Steer SA, Corbett JA, (2003) The role and regulation of COX-2 during viral infection. Viral Immunol 16: 447-460. doi:10.1089/088282403771926283. PubMed: 14733733.
45. Natarajan G, Glibetic M, Raykova V, Ofenstein JP, Thomas RL, et al. (2007) Nitric oxide and prostaglandin response to group B streptococcal infection in the lung. Ann Clin Lab Sci 37: 170-176. PubMed: 17522374.
46. Xu F, Xu Z, Zhang R, Wu Z, Lim J-H, et al. (2008) Nontypeable Haemophilus influenzae induces COX-2 and PGE2 expression in lung epithelial cells via activation of p38 MAPK and NF-kappa B. Respir Res 9: 16. doi:10.1186/1465-9921-9-16. PubMed: 18237405.
47. Sadikot RT, Zeng H, Azim AC, Joo M, Dey SK, et al. (2007) Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2. Eur J Immunol 37: 1001-1009. doi:10.1002/eji.200636636. PubMed: 17330822.
48. Rangel Moreno J, Estrada García I, De La Luz García Hernández M, Aguilar Leon D, Marquez R, et al. (2002) The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106: 257-266. doi:10.1046/j.1365-2567.2002.01403.x. PubMed: 12047755. doi:10.1046/j.1365-2567.2002.01403.x PubMed: 12047755.
49. Aronoff DM, Bergin IL, Lewis C, Goel D, O'brien E, et al. (2012) E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae. Prostaglandins Other Lipid Mediat 98: 23-30. doi:10.1016/j.prostaglandins.2012.03.002. PubMed: 22575745.
50. Aronoff DM, Canetti C, Peters-Golden M, (2004) Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP. J Immunol 173: 559-565. PubMed: 15210817.
51. Serezani CH, Chung J, Ballinger MN, Moore BB, Aronoff DM, et al. (2007) Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am J Respir Cell Mol Biol 37: 562-570. doi:10.1165/rcmb.2007-0153OC. PubMed: 17585108.
52. Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M, (2008) Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol 39: 127-132. doi:10.1165/rcmb.2008-0091TR. PubMed: 18323530.
53. Kapoor M, Kojima F, Qian M, Yang L, Crofford LJ, (2006) Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis. FASEB J 20: 2387-2389. doi:10.1096/fj.06-6366fje. PubMed: 17023389.
54. Carey MA, Bradbury JA, Rebolloso YD, Graves JP, Zeldin DC, et al. (2010) Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. PLOS ONE 5: e11610. doi:10.1371/journal.pone.0011610. PubMed: 20657653.
55. Coomes SM, Wilke CA, Moore TA, Moore BB, (2010) Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant. J Immunol 184: 5130-5140. doi:10.4049/jimmunol.0901871. PubMed: 20348421.
56. Lauder SN, Taylor PR, Clark SR, Evans RL, Hindley JP, et al. (2011) Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity. Thorax 66: 368-374. doi:10.1136/thx.2010.150318. PubMed: 21310755.
57. Monrad SU, Kojima F, Kapoor M, Kuan EL, Sarkar S, et al. (2011) Genetic deletion of mPGES-1 abolishes PGE2 production in murine dendritic cells and alters the cytokine profile, but does not affect maturation or migration. Prostaglandins Leukot Essent Fatty Acids 84: 113-121. doi:10.1016/j.plefa.2010.10.003. PubMed: 21190819.
58. Wang M, Zukas AM, Hui Y, Ricciotti E, Puré E, et al. (2006) Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc Natl Acad Sci U_S_A 103: 14507-14512. doi:10.1073/pnas.0606586103. PubMed: 16973753.